DXCM NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

DexCom Inc · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 83.45 USD
16.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 20.3% above the Trend Line and sits at 95.9% of its 52-week range. The latest completed week returned 16.6%, after a 17.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 54/100 conviction, while the latest news-sentiment score is 61/100. Near-term considerations: price is close to its 52-week high.

Setup score 64 out of 100
Latest Close 83.45 USD 31 Jul 2026
1W Return 16.6% latest completed week
4W Return 17.1% short-term follow-through
12W Return 37.7% quarterly tape
Trend Breadth 21.2% 11 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 16.6% Latest completed week; four-week move 17.1%. Indicator stack 39/65 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 54/100 conviction; expected move 17.9%. News sentiment 61/100 66 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 20.3% above the Trend Line and sits at 95.9% of its 52-week range. The latest completed week returned 16.6%, after a 17.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6812-week average 0.36

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 17.1% over four weeks, 37.7% over 12 weeks, and 5.3% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W16.6%
4W17.1%
12W37.7%
26W14.3%
52W5.3%
Active trend streak8 weeks
Active weeks in one year11
Trend breadth21.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.84Latest activity-pressure read.
Pressure change-2.2%Four-week change in activity pressure.
Leadership10.50Latest relative-leadership reading.
RS change191.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength18/100Blend of value, momentum, and quality. Underlying universe rank 83; rank 1 is best.
Value11/100Relative valuation strength. Underlying universe rank 90; rank 1 is best.
Quality100/100Profitability and accounting quality. Underlying universe rank 1; rank 1 is best.
Momentum15/100Medium-term price momentum. Underlying universe rank 86; rank 1 is best.
Growth93/100Revenue and earnings growth. Underlying universe rank 8; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
29.7x
Price divided by trailing earnings.
Price / sales
5.7x
Market value relative to trailing revenue.
EV / EBITDA
18.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
61.8%
Gross profit retained from each unit of revenue.
Operating margin
25.3%
Operating profit retained from revenue.
Free-cash-flow margin
44.3%
Free cash flow generated from revenue.
Return on invested capital
29.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
16.1%
Latest one-year revenue growth.
EPS growth
73.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
57.8%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
1.7%
Net share repurchases relative to market value.
Shareholder yield
1.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

DXCM shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.29, expected move of 17.9%, and Sharemaestro trend signal active.

Conviction54/100
Expected move17.9%
Put/call volume0.29
Pressure53
Speculation42
Volatility96
Trend agreement48
Open options detail
Insider activity10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment61/100

Weighted news tone is neutral across 66 relevant articles.

26 positive · 38 neutral · 2 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move17.9%Nearest-chain priced movement where available.
52-week drawdown-1.5%Distance below the 52-week high.
13-week volatility6.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+17.0%Week of 22 May.
Worst week-7.3%Week of 6 Mar.
Latest week+16.6%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains8
Flat weeks0
Modest losses8
Sharp losses5
Recent vol6.8%13-week weekly-return volatility.
Base vol5.7%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis57/100

Latest 12-week confirmation: trend 8/12, activity pressure 10/12, relative leadership 1/12.

Activity pressure 0.68; No reversal markers Factors36/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 25 SVQF47/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 382.5 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options50/100

DXCM shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.29, expected move of 17.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 17.9% Sentiment61/100

Weighted news tone is neutral across 66 relevant articles.

Stifel raises DexCom stock price target to $95 on strong results Insiders10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202683.45 USD16.6%69.36 USD86.55 USD0.8410.5033.0MOn
24 Jul 202671.54 USD-6.7%68.80 USD86.78 USD0.66-5.1217.1MOn
17 Jul 202676.65 USD2.3%68.66 USD87.17 USD0.76-0.8823.4MOn
10 Jul 202674.96 USD5.2%68.31 USD87.52 USD0.76-7.7423.6MOn
3 Jul 202671.25 USD1.6%68.04 USD87.92 USD0.86-11.4416.4MOn
26 Jun 202670.14 USD-3.2%67.85 USD88.27 USD0.91-12.8126.7MOn
19 Jun 202672.47 USD-3.8%67.63 USD88.65 USD0.90-14.8121.5MOn
12 Jun 202675.37 USD3.4%67.22 USD89.00 USD0.89-9.8629.4MOn
5 Jun 202672.86 USD-1.2%66.64 USD89.35 USD0.51-11.6025.2MOff
29 May 202673.74 USD2.3%66.05 USD89.68 USD0.16-15.4126.1MOff
22 May 202672.10 USD17.0%65.53 USD89.99 USD-0.10-15.8051.8MOff
15 May 202661.63 USD1.7%65.47 USD90.27 USD-0.55-27.9233.9MOff
8 May 202660.61 USD-1.2%65.64 USD90.62 USD-0.55-30.2126.2MOff
1 May 202661.35 USD-0.4%65.79 USD91.01 USD-0.59-26.5031.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.